Research & Insights
February 20, 2024
Lazard Healthcare Services Leaders Study 2024
Lazard Healthcare Services Leaders Study 2024
Lazard Global Biopharmaceutical Leaders Study 2023
The biopharma industry continues to be challenged by increased equity market volatility, following a period of unprecedented optimism and interest from generalists during the COVID-19 pandemic.
Lazard Global Medical Devices, Diagnostics and Tools Leaders Study 2023
The medical devices, diagnostics and life sciences tools (“tools”) industry is undergoing a period of transformation, driven by rapid technological innovation and a need for greater product affordability.